The Food and Drug Administration Dec. 4 announced empty IV bags have been added to its Medical Device Shortages List, and ...

CMS has reached agreements with bluebird bio and Vertex Pharmaceuticals for their FDA-approved gene therapies for sickle cell disease — Casgevy and Lyfgenia, respectively.

Novartis failed to persuade a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals' proposed generic of Novartis' ...

A history of lead in gasoline may be behind tens of millions of mental health conditions in the United States, according to ...

Fact-checking claims about "gender-affirming care" made in the Supreme Court oral arguments in the transgender case U.S. v.

A litter of puppies became ill after eating the mix, a customer told the Virginia Department of Agriculture and Consumer ...

The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, expanding treatment ...

The FDA granted breakthrough therapy status to sacituzumab tirumotecan in EGFR-mutated advanced non–small cell lung cancer.

Sana Biotechnology results from the phase 1 study using SC291 for the treatment of patients with SLE are expected in 2025.

According to the Food and Drug Administration, the cucumbers were grown in Sonora, Mexico and sold to the three companies ...

Anyone who thinks they may have suffered a reaction due to undeclared allergens should also "notify the FDA and local health ...